Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain

• DOI: 10.1186/s12917-018-1451-y
• Publication Date: 2018-04-19T11:24:54Z
• Authors: Tatjana Sattler; Jutta Pikalo; Eveline Wodak; Sandra Revilla-Fe...; Adi Steinrigl; Zoltán Bagó; Ferdinand Entenfe...; Jean-Baptiste Claude; Floriane Pez; Maela Francillette; Friedrich Schmoll
• Keywords: HP PRRSV 2; Male; 0301 basic medicine; 2. Zero hunger; Efficacy; Swine; Veterinary medicine; Porcine Reproductive and Respiratory Syndrome; Enzyme-Linked Immunosorbent Assay; Viral Vaccines; Sequence Analysis, DNA; Real-Time Polymerase Chain Reaction; Vaccines, Attenuated; 3. Good health; 03 medical and health sciences; Treatment Outcome; SF600-1100; Viral replication; Animals; RNA, Viral; Porcine respiratory and reproductive syndrome virus; Immune response; Vaccine; Research Article

Effective vaccines against porcine reproductive and respiratory syndrome virus (PRRSV), especially against highly pathogenic (HP) PRRSV are still missing. The objective of this study was to evaluate the protective efficacy of an experimental live attenuated PRRSV 2 vaccine, composed of two strains, against heterologous challenge with a Vietnamese HP PRRSV 2 field strain. For this reason, 20 PRRSV negative piglets were divided into two groups. The pigs of group 1 were vaccinated with the experimental vaccine, group 2 remained unvaccinated. All study piglets received an intranasal challenge of the HP PRRSV 2 on day 0 of the study (42 days after vaccination). Blood samples were taken on days 7 and 21 after vaccination and on several days after challenge. On day 28 after challenge, all piglets were euthanized and pathologically examined.On days 7 and 21 after vaccination, a PRRSV 2 viraemia was seen in all piglets of group 1 which remained detectable in seven piglets up to 42 days after vaccination. On day 3 after challenge, all piglets from both groups were positive in PRRSV 2 RT-qPCR. From day 7 onwards, viral load and number of PRRSV 2 positive pigs were lower in group 1 than in group 2. All pigs of group 1 seroconverted after PRRSV 2 vaccination. PRRSV antibodies were detected in serum of all study pigs from both groups from day 14 after challenge onwards. In group 2, moderate respiratory symptoms with occasional coughing were seen following the challenge with HP PRRSV 2. Pigs of group 1 remained clinically unaffected. Interstitial pneumonia was found in four piglets of group 1 and in all ten piglets of group 2. Histopathological findings were more severe in group 2.It was thus concluded that the used PRRSV 2 live experimental vaccine provided protection from clinical disease and marked reduction of histopathological findings and viral load in pigs challenged with a Vietnamese HP PRRSV 2 field strain.